[Review article. Molecular basis of antimycotic therapy].
A review is presented on the hitherto clinically administered antimycotic drugs, their action mechanisms and limitations as well as on the presently newly developed antifungals and their molecular targets.
Bastert
J
J
Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, München, Deutschland.
Korting
H C
HC
D000666:Amphotericin B / Q000378:metabolism / Q000627:therapeutic use; D000935:Antifungal Agents / Q000378:metabolism* / Q000627:therapeutic use*; D001393:Azoles / Q000378:metabolism / Q000627:therapeutic use; D009181:Mycoses / Q000188:drug therapy*; D011090:Polyenes / Q000378:metabolism / Q000627:therapeutic use; D011743:Pyrimidines / Q000378:metabolism / Q000627:therapeutic use
D000935:Antifungal Agents; D001393:Azoles; D011090:Polyenes; D011743:Pyrimidines; D000666:Amphotericin B
Ubersichtsartikel. Molekulare Grundlagen der antimykotischen Therapie.